Transcriptomics

Dataset Information

0

Post-epidemic eosinophilia myalgia syndrome associated with L-Tryptophan


ABSTRACT: Eosinophilia–myalgia syndrome (EMS) is characterized by subacute onset of myalgias and peripheral eosinophilia, followed by chronic neuropathy and skin induration. The EMS epidemic in 1989 was linked to L-tryptophan consumption originating from a single source. Following the Food and Drug Administration (FDA) ban on the sale of L-tryptophan, the incidence of EMS declined rapidly. Moreover, no new cases have been published since the FDA ban was lifted in 2005. We report the clinical, histopathological and immunogenetic features of a new case of L-tryptophan-associated EMS along with evidence of activated transforming growth factor-ß and interleukin-4 signaling in the lesional skin.

ORGANISM(S): Homo sapiens

PROVIDER: GSE26934 | GEO | 2012/01/28

SECONDARY ACCESSION(S): PRJNA136089

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-01-28 | E-GEOD-26934 | biostudies-arrayexpress
| PRJNA136089 | ENA
2016-04-20 | GSE66664 | GEO
2017-07-10 | GSE94937 | GEO
2025-04-16 | GSE292134 | GEO
2025-02-22 | GSE278827 | GEO
2023-12-23 | PXD048093 | Pride
2022-09-27 | GSE184866 | GEO
2022-09-27 | GSE184501 | GEO
2021-03-05 | GSE168214 | GEO